SEC Form 4 · accession 0001078782-17-000428
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin Charles Faulkes
Director
Period of report
Apr 3, 2017
Accepted (ET)
Apr 5, 2017 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 3, 2017 | X | 58,034 | $2.60 | A | 1,351,284 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy) | $2.60 | Apr 3, 2017 | X | 58,034 | D | May 11, 2012 | May 10, 2017 | Common Stock | 58,034 | 0 | D |